Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 17251-17300 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT03498040
Development and Progression of Carcinoid Heart Disease in a Cohort of Adult Patients With Neuroendocrine Tumors
N/AActive, not recruiting
670 participants
Started: Apr 16, 2018 · Completed: Apr 16, 2033
1 condition1 sponsor19 locations
NCT03230526
Identification of a Biomarker Predictive of Evolution of Parkinson Disease
PHASE2Active, not recruiting
31 participants
Started: Apr 16, 2018 · Completed: May 6, 2024
1 condition1 sponsor4 locations
NCT03568448
Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging
N/AActive, not recruiting
30 participants
Started: Apr 16, 2018 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT03493048
Cetuximab Plus FOLFOXIRI vs Cetuximab Plus FOLFOX For CRCLM
PHASE2Active, not recruiting
146 participants
Started: Apr 15, 2018 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT03339258
A Randomized Controlled Trial of Doxazosin for Nightmares, Sleep Disturbance, and Non-Nightmare Clinical Symptoms in PTSD
PHASE2Active, not recruiting
80 participants
Started: Apr 15, 2018 · Completed: Jun 30, 2024
1 condition3 sponsors1 location
NCT03451799
Ketogenic Diet in Combination With Standard-of-care Radiation and Temozolomide for Patients With Glioblastoma
PHASE1Active, not recruiting
21 participants
Started: Apr 13, 2018 · Completed: May 31, 2026
2 conditions1 sponsor1 location
NCT03555019
Nutrition Therapy in the Immature Infant (ImNuT)
NAActive, not recruiting
121 participants
Started: Apr 13, 2018 · Completed: May 30, 2029
2 conditions4 sponsors1 location
NCT03466411
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
PHASE2/PHASE3Active, not recruiting
1,409 participants
Started: Apr 13, 2018 · Completed: Jan 28, 2028
1 condition1 sponsor576 locations
NCT03394079
Optical Coherence Tomography Versus Intravascular Ultrasound Guided Percutaneous Coronary Intervention
NAActive, not recruiting
2,008 participants
Started: Apr 12, 2018 · Completed: Jan 31, 2028
1 condition2 sponsors9 locations
NCT03466151
RESOLUTE ONYX China RCT Study
NAActive, not recruiting
550 participants
Started: Apr 12, 2018 · Completed: Sep 19, 2025
5 conditions1 sponsor2 locations
NCT03470922
A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma
PHASE2/PHASE3Active, not recruiting
714 participants
Started: Apr 11, 2018 · Completed: Dec 15, 2030
1 condition1 sponsor127 locations
NCT03444181
ALzheimer and MUsic THerapy: Effects of Music Lessons on Brain Plasticity, Mood, and Quality of Life in Alzheimer Patients
NAActive, not recruiting
136 participants
Started: Apr 11, 2018 · Completed: Jun 14, 2024
3 conditions3 sponsors1 location
NCT03403257
Brain Attack Surveillance in Corpus Christi--Cognitive (BASIC-Cognitive)
N/AActive, not recruiting
634 participants
Started: Apr 11, 2018 · Completed: Apr 30, 2027
4 conditions2 sponsors1 location
NCT03442231
Journey™ UNI Post Market Clinical Follow-Up
N/AActive, not recruiting
147 participants
Started: Apr 11, 2018 · Completed: Apr 11, 2025
1 condition1 sponsor4 locations
NCT03485677
Safety and Efficacy of Eliglustat With or Without Imiglucerase in Pediatric Patients With Gaucher Disease (GD) Type 1 and Type 3
PHASE3Active, not recruiting
57 participants
Started: Apr 11, 2018 · Completed: Nov 20, 2025
2 conditions1 sponsor21 locations
NCT03428581
Preventing Lymphedema in Axillary Lymph Node Dissection
NAActive, not recruiting
264 participants
Started: Apr 10, 2018 · Completed: Feb 28, 2026
3 conditions1 sponsor2 locations
NCT03457935
Detection of Early Idiopathic Pulmonary Fibrosis
N/AActive, not recruiting
450 participants
Started: Apr 10, 2018 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT03474770
BIS-001-ER for the Treatment of Adult Focal Impaired Awareness Seizures
PHASE1/PHASE2Active, not recruiting
16 participants
Started: Apr 10, 2018 · Completed: Dec 30, 2026
1 condition1 sponsor2 locations
NCT04063826
PET-MR Study of Fatty Liver
NAActive, not recruiting
10 participants
Started: Apr 10, 2018 · Completed: Dec 31, 2023
1 condition1 sponsor1 location
NCT03407144
Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)
PHASE2Active, not recruiting
340 participants
Started: Apr 9, 2018 · Completed: Feb 13, 2027
1 condition1 sponsor93 locations
NCT03105102
A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
PHASE3Active, not recruiting
1,336 participants
Started: Apr 9, 2018 · Completed: May 31, 2026
1 condition1 sponsor496 locations
NCT03445559
A Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer Imaging
NAActive, not recruiting
58 participants
Started: Apr 9, 2018 · Completed: Feb 28, 2026
1 condition1 sponsor11 locations
NCT03477539
Daratumumab in Treating Transplant-Eligible Patients With Multiple Myeloma
PHASE2Active, not recruiting
50 participants
Started: Apr 9, 2018 · Completed: Dec 18, 2026
1 condition1 sponsor1 location
NCT03317990
Evaluating the Effects of Frozen Section Technology on Oncological and Functional Outcomes at Radical Prostatectomy.
NAActive, not recruiting
407 participants
Started: Apr 9, 2018 · Completed: Dec 31, 2027
1 condition5 sponsors5 locations
NCT03493516
Prediction of ARrhythmic Events With Positron Emission Tomography II
N/AActive, not recruiting
302 participants
Started: Apr 8, 2018 · Completed: Dec 31, 2025
3 conditions3 sponsors1 location
NCT04048330
Periconceptional Surveillance in India
N/AActive, not recruiting
2,000 participants
Started: Apr 7, 2018 · Completed: Dec 31, 2024
3 conditions4 sponsors1 location
NCT03428646
Study of Patients Receiving DUPIXENT® for Atopic Dermatitis (AD)
N/AActive, not recruiting
858 participants
Started: Apr 6, 2018 · Completed: Mar 30, 2027
1 condition2 sponsors99 locations
NCT03579901
Study of the Safety and Effectiveness of Motiva Implants®
NAActive, not recruiting
800 participants
Started: Apr 6, 2018 · Completed: Feb 28, 2033
1 condition1 sponsor29 locations
NCT05264532
Usefulness of Video-Based Intervention in Helping Participants Encourage Their Families to Get Tested for BRCA Gene Mutations
NAActive, not recruiting
58 participants
Started: Apr 5, 2018 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT03655561
Lassa Fever Clinical Course and Prognostic Factors in Nigeria
N/AActive, not recruiting
1,200 participants
Started: Apr 5, 2018 · Completed: Dec 31, 2025
6 conditions12 sponsors2 locations
NCT03473743
A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer
PHASE1/PHASE2Active, not recruiting
125 participants
Started: Apr 5, 2018 · Completed: Dec 31, 2026
1 condition1 sponsor127 locations
NCT03932383
3D Printer Modified CPAP Mask for Obstructive Sleep Apnea
NAActive, not recruiting
20 participants
Started: Apr 4, 2018 · Completed: Jul 1, 2021
1 condition1 sponsor1 location
NCT03377881
Prostate Cancer Detection Using the Stockholm3 Test and MR/Fusion Biopsies
NAActive, not recruiting
12,750 participants
Started: Apr 4, 2018 · Completed: Dec 10, 2030
1 condition1 sponsor3 locations
NCT03206801
Urine CXCL10 Monitoring Trial in Kidney Transplant
PHASE2/PHASE3Active, not recruiting
420 participants
Started: Apr 3, 2018 · Completed: Sep 26, 2025
2 conditions3 sponsors9 locations
NCT03489629
STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)
PHASE2Active, not recruiting
42 participants
Started: Apr 3, 2018 · Completed: Dec 30, 2025
1 condition7 sponsors9 locations
NCT03744000
Deferred Stenting in Patients With Anterior Wall STEMI
NAActive, not recruiting
185 participants
Started: Apr 3, 2018 · Completed: Nov 30, 2025
2 conditions3 sponsors1 location
NCT03314181
A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma
PHASE2Active, not recruiting
156 participants
Started: Apr 2, 2018 · Completed: May 31, 2031
1 condition2 sponsors40 locations
NCT03462498
ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study for the Patients With ACS
PHASE4Active, not recruiting
3,008 participants
Started: Apr 2, 2018 · Completed: Mar 31, 2026
5 conditions1 sponsor1 location
NCT03873363
Clinical Outcome After Total Knee Arthroplasty Using CR or PS Inlay
NAActive, not recruiting
140 participants
Started: Apr 1, 2018 · Completed: Sep 1, 2030
1 condition1 sponsor1 location
NCT03847285
Immune Function as Predictor of Infectious Complications and Clinical Outcome in Patients Undergoing Solid Organ Transplantation
N/AActive, not recruiting
188 participants
Started: Apr 1, 2018 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT03917498
Single Pre-Operative Radiation Therapy - With Delayed Surgery for Low Risk Breast Cancer
NAActive, not recruiting
20 participants
Started: Apr 1, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03573960
A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer
PHASE4Active, not recruiting
50 participants
Started: Apr 1, 2018 · Completed: Apr 30, 2025
1 condition1 sponsor11 locations
NCT03870464
LIFE - Lung Cancer, Immunotherapy, Frailty, Effect
N/AActive, not recruiting
150 participants
Started: Apr 1, 2018 · Completed: Apr 1, 2028
4 conditions5 sponsors1 location
NCT03420482
Fecal Microbiota Transplant As Treatment of Hepatic Encephalopathy
PHASE2Active, not recruiting
30 participants
Started: Apr 1, 2018 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT04537416
Fertility, Hypercoagulability, and Inflammation (FREYA) Registry
N/AActive, not recruiting
1,000 participants
Started: Apr 1, 2018 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT03356405
Evaluating Treatment as Prevention Among People Who Inject Drugs in Dundee for HCV
N/AActive, not recruiting
2,800 participants
Started: Apr 1, 2018 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT03344965
Olaparib In Metastatic Breast Cancer
PHASE2Active, not recruiting
114 participants
Started: Apr 1, 2018 · Completed: Dec 30, 2025
10 conditions4 sponsors20 locations
NCT04692012
Treatment of Residual Hypermetropic Refraction on Pseudophakic Patients Using Allogenic Fresh Myopic Lenticule
NAActive, not recruiting
34 participants
Started: Apr 1, 2018 · Completed: Feb 1, 2027
3 conditions1 sponsor1 location
NCT03292198
Subclinical Lymphedema Treatment Study
NAActive, not recruiting
267 participants
Started: Apr 1, 2018 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT03430609
Ovarian Function After Use of Various Hemostatic Techniques During Treatment for Endometrioma
NAActive, not recruiting
38 participants
Started: Apr 1, 2018 · Completed: Aug 31, 2020
4 conditions3 sponsors1 location